Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,89 USD | +4,42% | +11,18% | -83,83% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 6,97 mln. 6,52 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -31 mln. -28,99 mln. | Nettowinst (verlies) 2025 * | -34 mln. -31,8 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | 22 mln. 20,58 mln. | Nettoliquiditeiten 2025 * | 58 mln. 54,25 mln. | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-0,37
x | K/w-verhouding 2025 * |
-0,93
x | Werknemers | 14 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 96,06% |
Recentste transcriptie over eFFECTOR Therapeutics, Inc.
1 dag | +4,42% | ||
1 week | +11,18% | ||
Lopende maand | -86,87% | ||
1 maand | -85,36% | ||
3 maanden | -82,09% | ||
6 maanden | -85,76% | ||
Lopend jaar | -83,83% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Worland
CEO | Chief Executive Officer | 66 | 01-05-12 |
Michael Byrnes
DFI | Director of Finance/CFO | 47 | 01-12-20 |
Douglas Warner
CTO | Chief Tech/Sci/R&D Officer | 52 | 08-08-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Worland
CEO | Chief Executive Officer | 66 | 01-05-12 |
Director/Board Member | 54 | 25-08-21 | |
Caroline Loewy
BRD | Director/Board Member | 58 | 11-09-23 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 1,89 | +4,42% | 162 186 |
25-04-24 | 1,81 | -2,16% | 180 978 |
24-04-24 | 1,85 | -4,64% | 108 175 |
23-04-24 | 1,94 | +8,99% | 149 714 |
22-04-24 | 1,78 | +4,71% | 177 232 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-83,83% | 6,97 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |